Imaging plays a crucial role in identifying, diagnosing, treatment, and surveillance of pancreatic neuroendocrine tumors (PNETs). Although computed tomography has been traditionally used for evaluation of PNETs, evolving techniques with MR imaging have broadened and strengthened its role as an important tool in diagnosis, staging, and assessment of response to therapy.